AnaptysBio Inc. logo

AnaptysBio Inc.

ANAB | NASDAQ
Chart Builder DCF Calculator
$47.43
-$0.85 (-1.76%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
238.2M 123.08M 35.97M 71.31M 495.73M 250.46M
Short-Term Investments
73.44M 262.29M 354.94M 369.93M 52.37M 143.2M
Long-Term Investments
n/a 35.47M 27.03M 142.94M 67.1M 17.55M
Other Long-Term Assets
256K 256K 256K 256K 256K 318K
Receivables
33.85M 40.77M 6.85M 1.42M 876K n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
4.76M 5.74M 9.08M 4.55M n/a n/a
Total Current Assets
350.25M 431.88M 406.84M 447.21M 553.88M 396.56M
Property-Plant & Equipment
13.89M 16.23M 18.27M 19.99M 21.84M 2.13M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
14.15M 51.96M 45.55M 163.18M 89.19M 19.99M
Total Assets
364.4M 483.83M 452.39M 610.38M 643.07M 416.55M
Account Payables
3.87M 4M 4.7M 2.78M 1.74M 4.22M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a 1.93M n/a n/a n/a n/a
Other Current Liabilities
11.09M 31.05M 23.77M 5.38M 4.18M 3.69M
Total Current Liabilities
38.63M 45.43M 37.44M 26.05M 16.1M 19.82M
Long-Term Debt
12.03M 353.43M n/a n/a n/a n/a
Other Long-Term Liabilities
276.53M n/a 310.81M 304.41M 251.09M n/a
Total Long-Term Liabilities
288.56M 367.54M 326.84M 322.23M 270.54M n/a
Total Liabilities
327.19M 412.97M 364.29M 348.28M 286.64M 19.82M
Total Debt
14.11M 369.46M 17.81M 19.45M 20.96M 342K
Book Value
37.21M 70.87M 88.1M 262.1M 356.43M 396.73M
Book Value Per Share
1.19 2.50 3.27 9.31 12.99 14.53
Common Stock
28K 30K 27K 29K 28K 27K
Retained Earnings
-772.56M -759.33M -614.1M -450.48M -321.75M -263.96M
Comprehensive Income
-24K 305K -797K -5.25M -422K -4K
Shareholders Equity
37.21M 70.87M 88.1M 262.1M 356.43M 396.73M
Total Investments
73.44M 297.76M 381.97M 512.87M 119.47M 160.74M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.